<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00913068</url>
  </required_header>
  <id_info>
    <org_study_id>version 1September 102008</org_study_id>
    <nct_id>NCT00913068</nct_id>
  </id_info>
  <brief_title>Postoperative Pain Control for Prostatectomy</brief_title>
  <acronym>TAP</acronym>
  <official_title>Post Operative Analgesia Using the Transverse Abdominal Plan (TAP) Block in Patients Undergoing a Radical Retropubic Prostatectomy (RRP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Scotia Health Authority</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers propose to investigate a relatively new anesthetic procedure, in order to
      maximize patient comfort and minimize the use of narcotics after a radical prostatectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our current post operative analgesic strategy involves a multi-modal approach, using local
      injectable anesthetic around the incision and systemic medications (i.e. non-steroidal
      anti-inflammatories, acetaminophen and break-through doses of opiates). As the amount of
      opiates used can be significant, we have to be aware of their inherent risks. Opiates have an
      excellent pain control profile, working peripherally by decreasing the amount of
      neurotransmitters released from neurons involving noxious stimuli, and also in their central
      processing. Some of the more common adverse reactions are reparatory depression, sedation,
      confusion, delirium, nausea, pruritis, constipation, hypotension and bradycardia. Often it is
      these resulting side effects that extend the length of in hospital rehabilitation, and
      decrease a patient's overall satisfaction.

      Thus we propose the use of a relatively new regional anesthetic technique be employed to
      further decrease the need for opiates in our prostatectomy patients' post-op course, while
      adequately controlling their pain.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To investigate the analgesic efficacy and safety of the TAP block, in comparison to our standard of care in the peri-operative setting.</measure>
    <time_frame>assessments along with patients' vitals will be completed at 2, 6, 12, 24, 48 and 72 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the practical utility of a surgeon administered regional block during a radical prostatectomy</measure>
    <time_frame>during surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>TAP arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in the experimental arm, the procedure will consist of the staff urologist injecting local anesthetic into the anterior abdominal wall bilaterally from the inside of the abdomen at the end of their surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard post operative pain control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Our current post operative analgesic strategy involves a multi-modal approach, using local injectable anesthetic around the incision and systemic medications (i.e. non-steroidal anti-inflammatories, acetaminophen and break-through doses of opiates). Some of the more common adverse reactions are reparatory depression, sedation, confusion, delirium, nausea, pruritis, constipation, hypotension and bradycardia. Often it is these resulting side effects that extend the length of in hospital rehabilitation, and decrease a patient's overall satisfaction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transverse Abdominal Plan (TAP)</intervention_name>
    <description>An injectable anesthetic is introduced to a specific anatomic area where the sensory neurons supplying the operative field.</description>
    <arm_group_label>TAP arm</arm_group_label>
    <other_name>lidocaine</other_name>
    <other_name>ropivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>standard post op pain control</intervention_name>
    <description>opiates</description>
    <arm_group_label>standard post operative pain control</arm_group_label>
    <other_name>timed assessments for pain and medications</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  prostate cancer for radical prostatectomy

        Exclusion Criteria:

          -  chronic pain or opiate use
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo A Rendon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Elizabeth Health Sciences Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ricardo A Rendon, MD</last_name>
    <phone>902-425-3940</phone>
    <email>rrendon@dal.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Queen Elizabeth Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susan J Winch, BScN</last_name>
      <phone>902-473-6604</phone>
      <email>susan.winch@cdha.nshealth.ca</email>
    </contact>
    <investigator>
      <last_name>Shuba De, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David G Bell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ricardo A Rendon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Lawen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Greg Bailly, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Norman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Grantmyre, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2009</study_first_submitted>
  <study_first_submitted_qc>June 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2009</study_first_posted>
  <last_update_submitted>June 2, 2009</last_update_submitted>
  <last_update_submitted_qc>June 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Ricardo Rendon</name_title>
    <organization>Queen Elizabeth Health sciences Centre</organization>
  </responsible_party>
  <keyword>radical prostatectomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

